Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Cipla

Sector: Healthcare | Industry: Drugs & Pharma
R 453.00 -1.85  | -0.41% -14.22% 22.16 36,536.79
NSE Price: Nov 13, 11:44 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 13, 11:44 453.00 -1.85 -0.41% 452.00 454.85 1,589,465 449.00 - 455.00
BSE Nov 13, 11:31 452.10 -2.40 -0.53% 453.00 454.50 26,924 449.00 - 455.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,594,754 P/B: 2.34 NSE Code: CIPLA
52-Week Range: R 389.55 - 586.00 Dividend Yield: 0.66% BSE Code: 500087
TTM EPS: R 20.46 Book Value: R 193.48 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Cipla -12.44 3.06 -6.12 -13.61 -6.02 -6.51 4.08
S&P BSE Sensex 11.86 5.82 7.35 14.67 14.58 7.64 9.12
S&P BSE Healthcare -5.73 8.01 3.41 -10.61 -5.34 -2.65 10.93
Company's return has been calculated on basis of NSE's price.
As on Nov 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 7.96 6.37 9.97
Net Profit 6.36 2.66 1.28
EPS 8.23 3.85 1.86
Book Value 5.52 9.28 8.26
Average
Operating Margin 20.44 19.26 19.61
Net Margin 8.96 8.41 9.25
Return on Networth 10.37 9.91 10.89
Return on Investment 11.94 10.14 11.80
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 10.20 9.57 -0.19
Operating Profit 2.75 20.99 -4.39
Net Profit 2.08 31.22 28.60
EPS -1.46 24.88 28.30
TTM
Revenue 2.34 7.93 2.65
Operating Profit 4.79 19.87 7.32
Net Profit 7.45 20.26 9.16
EPS 6.04 17.06 7.88
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Cipla 36,536.79 16,796.32 1,647.89 9.61 10.37 2.34 22.16
Divi's Laboratories 44,444.75 5,143.19 1,289.02 24.33 21.00 6.28 34.48
Sun Pharmaceutical Inds. 101,539.86 31,401.82 4,850.97 14.99 8.05 2.34 23.45
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Oct 16, 2019 Ashwin Prakash Upasane  Buy ESOP 3,779 446.80 16.88
Oct 16, 2019 Sanjay S Bhanushali  Buy ESOP 21,051 446.80 94.06
Sep 16, 2019 Ajay Mangilal Luharuka  Buy ESOP 6,563 470.50 30.88
Sep 16, 2019 Kedar Upadhye  Buy ESOP 20,284 470.50 95.44
Sep 16, 2019 Kirit Dharanendra Ladage  Buy ESOP 2,175 470.50 10.23
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
ICICI Prudential Mutual Fund 5.645 3.988 3.451 3.652 3.635
HDFC Mutual Fund 2.537 2.528 2.514 2.686 2.713
SBI Mutual Fund 1.467 1.134 1.085 1.020 1.213
Nippon India Mutual Fund 1.458 1.763 1.270 0.861 0.745
UTI Mutual Fund 0.853 0.916 0.918 0.937 0.978
Aditya Birla Sun Life Mutual Fund 0.376 0.285 0.037 0.348 0.557
Kotak Mahindra Mutual Fund 0.225 0.223 0.049 0.153 0.008
L&T Mutual Fund 0.219 0.285 0.248 0.248 0.241
Mirae Asset Mutual Fund 0.160 0.208 0.503 0.500 0.276
IDFC Mutual Fund 0.070 0.052 0.020 0.003 0.002
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Cipla Ltd.

Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra - 400013 | Phone: 022-24826000 / 022-24826951 | Fax: 022-24826893

Email: [email protected]

Website: www.cipla.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
4.97
Piotroski F-Score
7
Modified C-Score
0
5-Years Price to Earnings
22.22
5-Years Price to Book
2.35
Earnings Yield
EBIT / Enterprise value
6.49%
PEG
Price / Earnings to growth ratio
3.42
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R443.00 +1.21%
Biocon R260.90 -0.99%
Cadila Healthcare R229.35 -0.48%
Divi's Laboratories R1,677.15 -1.95%
Dr. Reddy's Lab R2,770.00 -1.62%
Glaxosmithkline Pharma R1,606.55 -0.83%
Lupin R730.55 -0.71%
Piramal Enterprises R1,820.25 +2.20%
Sun Pharmaceutical Inds. R417.15 -1.02%
Torrent Pharmaceuticals R1,786.75 -0.93%
As on Nov 13, 11:44